Le Lézard
Classified in: Health
Subject: PLW

Circadiance Granted US and International Patents for SleepWeaver® Soft Cloth CPAP Masks


PITTSBURGH, Aug. 7, 2018 /PRNewswire-PRWeb/ -- Circadiance, a pioneer in respiratory therapy specializing in positive airway pressure, non-invasive ventilation and remote patient monitoring, announced today that it has received two additional patents for its SleepWeaver line of Soft Cloth CPAP Masks. The United States Patent and Trademark Office (USPTO) has granted a patent titled "Full Face Cloth Respiratory Mask" to Circadiance covering certain features of the SleepWeaver Anew Soft Cloth Full Face CPAP Mask under the patent number of 9,981,104. The United Kingdom Patent Office (UKIPO) has granted a patent titled "Improved Respiratory Mask with Disposable Cloth Body" covering certain features of the SleepWeaver Elan Soft Cloth CPAP Mask under the patent number of 2,504,598.

With the addition of these two patents, Circadiance holds 9 US and international patents around its cloth masks technology. "These patents provide further validation of the novelty of our CPAP mask solutions" said David Groll, founder, and CEO of Circadiance. "Circadiance customers report that CPAP masks made of cloth are more comfortable and easier to wear because they are lighter and softer than hard plastic CPAP masks."

The SleepWeaver line are the only cloth masks on the market. SleepWeaver Masks are for use in conjunction with Continuous Positive Airway Pressure (CPAP) or bi-level therapy, which is the most frequent treatment for Obstructive Sleep Apnea. SleepWeaver masks are the lightest and softest masks available to CPAP users. The masks provide enhanced comfort to the user because cloth allows the skin to breathe, without moisture accumulating between the mask and the user's skin. The soft cloth masks are particularly important for those CPAP users who experience skin reactions to hard plastic masks. The unique loose fit provides added comfort and reduces strap marks. All Circadiance masks allow for a variety of sleep positions.

SleepWeaver Anew® was launched in 2013. SleepWeaver Anew is an alternative to hard plastic masks for Full Face CPAP mask users. The mask features a dual interface design that seals around both the nose and the mouth, with only soft cloth touching the skin. SleepWeaver Anew is available in multiple sizes to ensure that users find the perfect fit for their face.

SleepWeaver Elan® was launched in 2012. SleepWeaver Elan is an alternative to hard plastic masks for Nasal CPAP mask users. The mask features a design that seals around the nose, again with only soft cloth touching the skin.SleepWeaver Elan is available in multiple sizes to ensure that users find the perfect fit for their face.

Each of these patent applications were filed prior to the launch of their respective products. It is not unusual for patents to issue years after the initial application filing. "The addition of these patents to our portfolio strengthens our intellectual property position in the global CPAP mask market" continued Groll. The market opportunity for CPAP Masks is large and growing. Available data indicate that the global market for CPAP Masks is approximately USD$2 billion, growing at a compound annual rate of 9.2% through to 2022.

About Circadiance:
Circadiance is a pioneer in respiratory therapy medical devices specializing in positive airway pressure, noninvasive ventilation and apnea monitoring. Our clinically proven, innovative solutions address patients ranging from premature newborns, pediatrics, children to adults. Circadiance's brands include the following:

SleepWeaver® ? Soft Cloth CPAP Masks

Smart Monitor® ? Infant Apnea Monitors

NeoPAP® ? Neonatal CPAP and High Flow Respiratory Support System

For more information about Circadiance, contact customer service at (888)-825-9640. International inquiries should call +1-724-858-2837. You can also visit Circadiance.com.

 

SOURCE Circadiance


These press releases may also interest you

at 11:37
According to data from the CDC, the construction industry has the highest overdose death rate across all industries1. Construction workers are five times more likely to die by suicide than safety-related issues2. BTEA is uniting the union...

at 11:35
A2 Biotherapeutics, Inc. (A2 Bio) a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today announced the acceptance of three posters for presentation...

at 11:28
Qualitas Dental Partners proudly announces its partnership with the foremost oral surgery group in New England, furthering its commitment to deliver patient-centric dental care across the region....

at 11:25
MAKO Medical, a leader in healthcare diagnostics and laboratory services, is honored to announce its partnership with Rebuilding Together, a renowned nonprofit organization focused on repairing homes, revitalizing communities, and rebuilding lives....

at 11:20
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company's request for an extension of its previously announced stay of proceedings under the Companies' Creditors Arrangement Act (the "CCAA") was heard before the Ontario...

at 11:15
The Human Animal Bond Research Institute (HABRI) today announced a new grant for research that investigates the contribution of pet dog ownership to resilience and well-being in adolescent children of military families. This grant was awarded to a...



News published on and distributed by: